Corpus Intelligence IC Memo — THE MEDICAL CENTER OF ALBANY 2026-04-26 23:28 UTC
IC Memo — THE MEDICAL CENTER OF ALBANY
Investment Committee Memorandum | KY | 20 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 180106

THE MEDICAL CENTER OF ALBANY

LOCATIONCLINTON, KY·BEDS20·AS OFApril 26, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

THE MEDICAL CENTER OF ALBANY is a 20-bed rural/critical access in CLINTON, KY with $14.7M in net patient revenue and a -12.2% operating margin. The hospital serves a payer mix of 50.8% Medicare, 4.0% Medicaid, and 45.2% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.2% to -4.8% (+736bps).

Net Revenue HCRIS$14.7M
Current EBITDA COMPUTED$-1.8M
Operating Margin COMPUTED-12.2%
Occupancy HCRIS35.5%
Revenue / Bed COMPUTED$735K
Net-to-Gross HCRIS28.1%
Distress Probability ML52.7%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
43
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -12.2% places it below the state median. Among 43 size-comparable peers (10-40 beds), the median margin is -0.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THE MEDICAL CENTER OF ALBANY (Target)KY20$14.7M-12.2%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%
ROCKCASTLE HOSPT. & RESPIR CARKY30$79.1M2.2%
HARRISON MEMORIAL HOSPITALKY34$67.8M-9.9%
OHIO COUNTY HOSPITALKY25$56.6M-6.8%
BOURBON COMMUNITY HOSPITALKY34$44.0M16.6%
SAINT JOSEPH BEREAKY25$40.0M3.9%
JAMES B HAGGIN MEMORIAL HOSPITKY25$38.9M12.2%
BARBOURVILLE ARH HOSPITALKY25$38.8M9.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$309K+210bp18mo
Cost to Collect4.5%2.5%$294K+200bp12mo
Denial Rate Reduction12.0%6.5%$291K+198bp12mo
A/R Days Reduction5200.0%3800.0%$179K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$309K
Cost to Collect
$294K
Denial Rate Reduction
$291K
A/R Days Reduction
$179K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-1.8M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$-710K
Current Margin-12.2%
Pro Forma Margin-4.8%
WC Released (1x)$564K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.8M$-996K0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.8M$-2.0M0.00x-100.0%
Bull Case9.0x11.0x$-2.5M$686K0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.5M$16K0.00x-100.0%
Bear Case11.0x10.0x$-3.0M$-5.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.0M$-7.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 52.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 10-40 beds
  • Same-state prioritization (n=44)
  • Comp margins: P25=-9.4% / P50=-0.1% / P75=8.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.